ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Cognitive Dysfunction
Dementia
Mental Disorders
Brain Diseases
Psychotic Disorders
Neurodegenerative Diseases

Alzheimer's Disease trials near Warszawa, Mazowieckie, POL:

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (PRImus-AD)

Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...

Active, not recruiting
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease, Early Onset
Drug: Placebo
Drug: PRI-002

Phase 2

PRInnovation

Warsaw, Poland and 39 other locations

The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's...

Active, not recruiting
Alzheimer Disease
Drug: LY3372689
Drug: Placebo

Phase 2

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 69 other locations

versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study participants with prodromal or mild Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Other: Placebo
Biological: Bepranemab

Phase 2

UCB
UCB

Warszawa, Poland and 102 other locations

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Phase 3

AriBio

Warszawa, Poland and 102 other locations

This clinical trial is recruiting people who either are at risk of AD - have build-up of beta-amyloid, but have no clinical symptoms, or with a diagn...

Enrolling
Alzheimer's Disease
Drug: RO7269162
Drug: Placebo

Phase 2

Roche
Roche

Warszawa, Poland and 56 other locations

In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment or...

Active, not recruiting
Mild Cognitive Impairment Due to Alzheimer's Disease
Alzheimer's Disease Dementia
Drug: BIIB080-matching placebo
Drug: BIIB080

Phase 2

Biogen
Biogen

Warszawa, Poland and 137 other locations

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

Phase 3

Lilly
Lilly

Warszawa, Mazowieckie, Poland and 276 other locations

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo (semaglutide)
Drug: Semagludtide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 341 other locations

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...

Active, not recruiting
Early Alzheimer´s Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 384 other locations

The goal of this clinical study is to learn about an investigational gene therapy product called AVB-101, which is designed to treat a disease...

Enrolling
Dementia, Frontotemporal
Frontotemporal Dementia
Genetic: Intrathalamic AVB-101
Procedure: Intrathalamic AAV.PGRN administration

Phase 1, Phase 2

AviadoBio

Warsaw, Poland and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems